← Elevance Health, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product and service revenue | — | — | — | — | — | — | $22.4b | $27.4b | $31.0b | $32.9b | — | |
| Total Revenue | $84.9b |
$90.0b
+6.10%
|
$92.1b
+2.29%
|
$104.2b
+13.15%
|
$121.9b
+16.94%
|
$138.6b
+13.76%
|
$156.6b
+12.95%
|
$171.3b
+9.42%
|
$177.0b
+3.31%
|
$199.1b
+12.49%
|
$201.1b
+1.00%
|
|
| Insurance Services Revenue | $84.2b | $89.1b | $91.3b | $103.1b | $120.8b | $136.9b | $155.7b | — | — | — | — | |
| Cost of Revenue | $67.5b |
$73.2b
+8.46%
|
$72.7b
-0.76%
|
$2.0b
-97.26%
|
$9.0b
+349.45%
|
$10.9b
+21.69%
|
$13.0b
+19.64%
|
$17.3b
+32.67%
|
$19.8b
+14.21%
|
$21.2b
+7.23%
|
— | |
| Cost of products sold | — | $0 | $0 | $2.0b |
$9.0b
+349.45%
|
$10.9b
+21.69%
|
$13.0b
+19.64%
|
$17.3b
+32.67%
|
$19.8b
+14.21%
|
$21.2b
+7.23%
|
— | |
| Gross Profit (Calculated) | $17.4b |
$16.8b
-3.08%
|
$19.4b
+15.58%
|
$102.2b
+425.67%
|
$112.9b
+10.46%
|
$127.7b
+13.13%
|
$143.6b
+12.38%
|
$154.0b
+7.30%
|
$157.3b
+2.09%
|
$177.9b
+13.15%
|
— | |
| Marketing and Advertising Expense | $246.2m | $337.9m | $385.0m | $467.0m | $558.0m | $588.0m | $511.0m | $599.0m | $540.0m | $395.0m | — | |
| Selling, General and Administrative Expense | $12.6b | $12.6b | $14.0b | $13.4b | $17.4b | $15.9b | $17.7b | $20.1b | $20.0b | $21.0b | — | |
| Amortization of Intangible Assets | $192.3m | $168.4m | $358.0m | $338.0m | $361.0m | $441.0m | $767.0m | $885.0m | $580.0m | $628.0m | — | |
| Restructuring and Related Cost, Incurred Cost | — | — | — | — | $653.0m | $202.0m | $39.0m | — | — | — | — | |
| Operating Income (Loss) | $4.8b |
$4.2b
-13.04%
|
$5.4b
+29.95%
|
$6.0b
+10.56%
|
$6.4b
+6.02%
|
$7.5b
+17.75%
|
$8.5b
+12.86%
|
$8.5b
+0.56%
|
$7.9b
-7.49%
|
$7.2b
-8.43%
|
— | |
| Interest Expense | $723.0m | $739.0m | $753.0m | $746.0m | $784.0m | $798.0m | $851.0m | $1.0b | $1.2b | $1.4b | $1.4b | |
| Investment Income, Net | $823.3m | $907.6m | $1.0b | $1.0b | $915.0m | $1.4b | $1.5b | $1.9b | $2.1b | $2.2b | — | |
| Net Investment Income | $779.5m | $866.5m | $970.0m | $1.0b | $877.0m | $1.4b | $1.5b | $1.8b | $2.1b | $2.2b | $1.1b | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | ($73.0m) | — | — | — | — | — | |
| Gain on sale of business | — | — | — | — | — | — | $0 | $0 | $201.0m | $0 | — | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | — | — | ($9.0m) | ($29.0m) | ($26.0m) | ($28.0m) | ($7.0m) | — | — | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | $562.0m | $293.0m | ($33.0m) | $1.0m | $398.0m | — | |
| Other Income | $35.1m | $33.1m | $5.9b | $9.0b | $6.3b | $6.9b | $7.5b | $7.9b | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | — | — | $6.3b | $5.9b | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $4.6b | $4.0b | $5.1b | $6.0b | $6.2b | $7.9b | $7.8b | $7.7b | $7.9b | $6.7b | $5.9b | |
| Current Income Tax Expense (Benefit) | $2.0b | $1.4b | $1.2b | $1.1b | $2.2b | $1.6b | $1.7b | $2.4b | $2.3b | $1.3b | $915.0m | |
| Income Tax Expense (Benefit) | $2.1b | $121.0m | $1.3b | $1.2b | $1.7b | $1.8b | $1.8b | $1.7b | $1.9b | $1.0b | $915.0m | |
| Net losses on financial instruments | — | — | — | — | — | $318.0m | ($550.0m) | ($694.0m) | ($445.0m) | ($653.0m) | — | |
| Net Income (Loss) Attributable to Parent | $2.5b |
$3.8b
+55.59%
|
$3.8b
-2.41%
|
$4.8b
+28.19%
|
$4.6b
-4.89%
|
$6.1b
+33.51%
|
$6.0b
-1.29%
|
$6.0b
-0.63%
|
$6.0b
-0.12%
|
$5.7b
-5.32%
|
$5.0b
-12.35%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | $0 | $0 | ($9.0m) | ($6.0m) | $4.0m | ($9.0m) | ($1.0m) | $5.0b | |
| Net loss (gain) attributable to noncontrolling interests | — | — | — | $0 | $0 | $9.0m | $6.0m | ($4.0m) | $9.0m | $1.0m | — | |
| Earnings Per Share, Basic | $9.39 | $14.70 | $14.53 | $18.81 | $18.23 | $25.04 | $25.10 | $25.38 | $25.81 | $25.28 | $22.67 | |
| Earnings Per Share, Diluted | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.73 | $24.81 | $25.22 | $25.68 | $25.21 | $22.61 | |
| Income (Loss) from Continuing Operations, Per Basic Share | $9 | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $9 | $14 | $14 | $18 | $18 | $25 | $25 | $25 | $26 | $25 | — | |
| Common Stock, Dividends, Per Share, Declared | $2.60 | $2.70 | $3.00 | $3.20 | $3.80 | $4.52 | $5.12 | $5.92 | $0.00 | $0.00 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 262.9m | 261.5m | 258.1m | 255.5m | 250.8m | 243.8m | 240.0m | 235.9m | 231.7m | 224.0m | 220.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 268.1m | 267.8m | 264.2m | 260.3m | 254.3m | 246.8m | 242.8m | 237.4m | 232.9m | 224.6m | 220.9m | |
| Expenses | ||||||||||||
| Amortization of other intangible assets | $192.3m | $168.4m | $358.0m | $338.0m | $361.0m | $441.0m | $767.0m | $885.0m | $580.0m | $628.0m | — | |
| Benefit expense | $66.8b | $72.2b | $71.9b | $81.8b | $88.0b | $102.6b | $116.5b | $124.3b | $127.6b | $148.2b | — | |
| Capitalized Computer Software, Amortization | — | $434.6m | $465.0m | $450.0m | $412.0m | $485.0m | $599.0m | $685.0m | $734.0m | $803.0m | — | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | $65.5b | $70.7b | $68.7b | $78.2b | $84.5b | $98.7b | $112.5b | $120.2b | $123.6b | $144.3b | — | |
| Operating expense | $12.6b | $12.6b | $14.0b | $13.4b | $17.4b | $15.9b | $17.7b | $20.1b | $20.0b | $21.0b | $195.3b | |
| Premiums | $78.9b | $83.6b | $85.4b | $94.2b | $104.1b | $117.4b | $133.2b | $142.9b | $144.2b | $164.6b | — | |
| Realized Investment Gains (Losses) | $220.1m | $200.3m | ($203.0m) | $131.0m | $184.0m | — | — | — | — | — | — | |
| Selling Expense | $1.4b | $1.4b | — | — | — | — | — | — | — | — | — | |
| Benefits, Losses and Expenses | $80.3b | $86.1b | $87.0b | $98.2b | $115.6b | $130.7b | $148.8b | $163.6b | $169.1b | $192.4b | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $2.5b | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $0 | — | — | $0 | $0 | $9.0m | $6.0m | $4.0m | $9.0m | $1.0m | — | |
| Policyholder Benefits and Claims Incurred, Net | $66.8b | $72.2b | $71.9b | $81.8b | $88.0b | $102.6b | $116.5b | $124.3b | $127.6b | $148.2b | — | |
| Total expenses | $80.3b | $86.1b | $87.0b | $98.2b | $115.6b | $130.7b | $148.8b | $163.6b | $169.1b | $192.4b | $195.3b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.